SanofivsThermo Fisher Scientific

SNY and TMO stock compared: price, dividend, valuation and results, from SEC filings.

TMO

Thermo Fisher Scientific Inc

$686.79

Value $255B

-0.66%
TMO's page

Sanofi (SNY) has a market value of $116B and Thermo Fisher Scientific (TMO) $255B. Over the last year, with dividends, SNY moved -3.7% and TMO +19.1%. The P/E is 12.6 for SNY and 36.1 for TMO. Dividend yield: SNY 4.84%, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    SNY$116B

    TMO$255B

    TMO is 2.2 times SNY

  • Revenue, 12 months

    SNY$51.2B

    TMO$47.4B

    SNY is 1.1 times TMO

  • Net income, 12 months

    SNY$9.2B

    TMO$7.1B

    SNY is 1.3 times TMO

  • Operating margin

    SNY14.5%

    TMO17.9%

    3.4 points apart

  • ROIC

    SNY5.8%

    TMO8.2%

    2.4 points apart

  • P/E

    SNY12.6

    TMO36.1

    TMO is 2.9 times SNY

  • Dividend yield

    SNY4.8%

    TMO0.3%

    4.5 points apart

  • 5-year return

    SNY+15.6%

    TMO+8.6%

    7.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

SNY+15.6%

TMO+8.6%

608010012020222023202420252026
Returns by period
PeriodSNYWith dividendsTMOWith dividends
1 year since November 14, 2025-3.7%Price -8.8%+19.1%Price +18.7%
3 years since November 17, 2023+16.1%+5.1% a yearPrice +1.1%+48.7%+14.1% a yearPrice +47.2%
5 years since November 16, 2021+15.6%+2.9% a yearPrice -6.6%+8.6%+1.7% a yearPrice +7.1%
10 years since November 17, 2016+74.6%+5.7% a yearPrice +16.0%+374.5%+16.8% a yearPrice +361.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

SNYSanofiTMOThermo Fisher Scientific

Valuation

SNYTMO
Valuation
Price$47.53$686.79
Market value$116B$255B
Enterprise value (EV)$126B$290B
P/E12.636.1
P/E, 5-year median17.332.7
P/B1.44.7
EV/EBIT16.934.3
Free cash flow yield7.3%3.0%

Results and growth

SNYTMO
Results and growth
Revenue, 12 months$51.2B$47.4B
Net income, 12 months$9.2B$7.1B
Free cash flow, 12 months$8.5B$7.6B
Earnings per share, 12 months$3.74$18.96
Revenue growth, year on year6.2%3.9%
Revenue growth a year, past+3.9%over 5 years+6.7%over 5 years
EPS growth a year, past-8.2%over 5 years+2.1%over 5 years

Margins and returns on capital

SNYTMO
Margins and returns on capital
Gross margin77.2%–
Operating margin14.5%17.9%
Net margin17.9%14.9%
ROIC5.8%8.2%
ROE10.9%13.4%

Balance sheet

SNYTMO
Balance sheet
Cash$9.0B$6.1B
Total debt$18.8B$41.4B
Net debt / EBITDA–3.7
Interest cover–5.5×

Dividends and buybacks

SNYTMO
Dividends and buybacks
Dividend yield4.8%0.3%
Dividend per share, 12 months$2.30$1.84
Dividend growth a year, past+3.6%over 5 years+14.3%over 5 years
Buyback yield5.1%1.2%
Shareholder yield9.9%1.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: SNY or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Sanofi or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($255B) is about 2.2 times Sanofi ($116B), at today's prices.

How did SNY and TMO stock do over the last 10 years?

Since November 17, 2016, SNY's price moved +16.0% and TMO's +361.3%. With dividends: SNY +74.6% (+5.7% a year), TMO +374.5% (+16.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, SNY or TMO?

The dividend yield at today's price is 4.84% for Sanofi and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid $2.30 and $1.84 per share.

What is the P/E of SNY and TMO?

At today's price, the P/E is 12.6 for SNY and 36.1 for TMO. The median of the last five years was 17.3 and 32.7, which shows where each stands against its own past.

Which has the higher profit margins, Sanofi or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 17.9% for Sanofi and 14.9% for Thermo Fisher Scientific, and the operating margin 14.5% and 17.9%. Revenue was $51.2B and $47.4B.

Which is the better investment, Sanofi or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.